Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 800 AM ET
HBIO Stock | USD 2.20 0.01 0.46% |
About 62% of all Harvard Bioscience's investors are looking to take a long position. The analysis of overall sentiment of trading Harvard Bioscience stock suggests that some investors are interested at this time. Harvard Bioscience's investing sentiment overview a quick insight into current market opportunities from investing in Harvard Bioscience. Many technical investors use Harvard Bioscience stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Harvard |
HOLLISTON, Mass., April 29, 2024 -- Harvard Bioscience, Inc. will announce its financial results for the quarter ended...
Read at globenewswire.com
Harvard Bioscience Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Harvard Bioscience can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Harvard Bioscience Fundamental Analysis
We analyze Harvard Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Harvard Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Harvard Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Ratio
Current Ratio Comparative Analysis
Harvard Bioscience is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Harvard Bioscience Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Harvard Bioscience stock to make a market-neutral strategy. Peer analysis of Harvard Bioscience could also be used in its relative valuation, which is a method of valuing Harvard Bioscience by comparing valuation metrics with similar companies.
Peers
Harvard Bioscience Related Equities
AKYA | Akoya Biosciences | 2.80 | ||||
ICUI | ICU Medical | 2.64 | ||||
LMAT | LeMaitre Vascular | 1.12 | ||||
INFU | InfuSystems Holdings | 0.45 | ||||
MMSI | Merit Medical | 0.23 | ||||
UTMD | Utah Medical | 0.15 | ||||
PDEX | Pro Dex | 0.02 | ||||
ANGO | AngioDynamics | 1.28 | ||||
KRMD | Repro Med | 1.49 | ||||
MLSS | Milestone Scientific | 2.94 | ||||
POCI | Precision Optics, | 4.17 |
Check out Harvard Bioscience Hype Analysis, Harvard Bioscience Correlation and Harvard Bioscience Performance. To learn how to invest in Harvard Stock, please use our How to Invest in Harvard Bioscience guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harvard Bioscience. If investors know Harvard will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harvard Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.80) | Earnings Share (0.33) | Revenue Per Share 2.258 | Quarterly Revenue Growth (0.13) | Return On Assets (0.02) |
The market value of Harvard Bioscience is measured differently than its book value, which is the value of Harvard that is recorded on the company's balance sheet. Investors also form their own opinion of Harvard Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Harvard Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harvard Bioscience's market value can be influenced by many factors that don't directly affect Harvard Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harvard Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harvard Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harvard Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.